Filing Details
- Accession Number:
- 0001127602-18-026096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-23 16:36:38
- Reporting Period:
- 2018-08-22
- Accepted Time:
- 2018-08-23 16:36:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1233311 | J Michael Coyle | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Evp & Group Pres, Cardiac&Vasc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-08-22 | 23,175 | $43.15 | 190,680 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-08-22 | 70,984 | $37.53 | 261,664 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-08-22 | 84,060 | $34.88 | 345,724 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-08-22 | 145,544 | $95.50 | 200,180 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-08-22 | 23,175 | $0.00 | 23,175 | $43.15 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-08-22 | 70,984 | $0.00 | 70,984 | $37.53 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-08-22 | 84,060 | $0.00 | 84,060 | $34.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-02-01 | No | 4 | M | Direct | |
| 0 | 2020-08-02 | No | 4 | M | Direct | |
| 0 | 2021-08-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 250 | Indirect | By Family Trust |
| Ordinary Shares | 4,104 | Indirect | By Spouse |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.365 to $95.665, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- This option to purchase 23,175 ordinary shares of New Medtronic for $43.15 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 23,175 Medtronic common stock shares for $43.15 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
Billionaire Hedge Funds
